Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03793127 · ClinicalTrials.gov registry record

Brown Adipose Tissue Pilot

A clinical trial of Aging, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
24
Enrollment target
1
Study location

NCT03793127 is a study of Aging that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 24 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03793127, a study of Aging, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this protocol is to develop a reliable method to determine BAT mass in young and older adults by magnetic resonance imaging.

Conditions Studied

Interventions

  • OTHER Maximal oxygen consumption (V02 max)
  • OTHER Brown adipose tissue (BAT) imaging
  • OTHER Muscle function testing

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-01-23
Est. Completion 2025-12

What the Registry Record Tells You About NCT03793127

The ClinicalTrials.gov registry entry for NCT03793127 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 3 interventions - of which Maximal oxygen consumption (V02 max) is the first listed.

NCT03793127 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03793127 about?

NCT03793127 is a clinical study titled "Brown Adipose Tissue Pilot". The primary purpose of this protocol is to develop a reliable method to determine BAT mass in young and older adults by magnetic resonance imaging.

What is the current status of trial NCT03793127?

This trial is currently active not recruiting. The enrollment target is 24 participants. The study started on 2019-01-23. Estimated completion is 2025-12.

What conditions does trial NCT03793127 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT03793127?

The interventions under investigation include: Maximal oxygen consumption (V02 max) (OTHER), Brown adipose tissue (BAT) imaging (OTHER), Muscle function testing (OTHER).

Who is sponsoring clinical trial NCT03793127?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03793127 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.